Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|14|6|843-852

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.14, Iss.6, 2017-09, pp. : 843-852

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelin and Subarachnoid Hemorrhage-Induced Cerebral Vasospasm: Pathogenesis and Treatment

By  

Current Medicinal Chemistry, Vol. 11, Iss. 13, 2004-07 ,pp. : 1779-1791

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C and are involved in the development of vasospasm after subarachnoid hemorrhage

By Nishizawa S.   Obara K.   Nakayama  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 113-119

Elsevier

Access to resources Recommend Favorite

Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage

By Macdonald R Loch  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1761-1767

Informa Healthcare

Access to resources Recommend Favorite

Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage

By Topcuogğlu Mehmet Akif   Singhal Aneesh B  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 57-65

Informa Healthcare

Access to resources Recommend Favorite

Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage

By Jain K.K.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 859-870

Informa Healthcare

Access to resources Recommend Favorite